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Abstract 
O&6 is a POU transcription factor that is thought to play a role in the differentiation of cells of neuroectodermal origin. To 
investigate whether the Ott-6 protein could play a role in the establishment of neuroectoderm in vivo we studied the expression of the 
Ott-6 protein during early mouse development. Expression is first observed in the primitive ectoderm of the egg cylinder stage embryo. 
In gastrulating embryos, Ott-6 protein is found in the extra-embryonic ectoderm of the chorion and the anterior ectoderm of the embryo 
proper. As development proceeds, Ott-6 expression becomes more restricted to the anterior medial part of the embryo until Ott-6 
positive cells are observed only in the neural groove of the headfold stage embryo. In the late headfold stage embryo, Ott-6 expression 
is detected in the neuroepithelium of the entire brain and later is restricted to a more ventral and anterior position. As the anterior 
neuropore closes, Ott-6 protein is detected in a segment-like pattern in the mid- and forebrain. Thus, the expression pattern of the Ott-6 
gene agrees with a role for the Ott-6 protein in the establishment and regional specification of the neuroectoderm in vivo. The two 
waves of widespread induction of the Ott-6 gene, one in the primitive ectoderm and another in the primitive brain, both followed by a 
progressive restriction in the expression patterns uggest amechanism for the regulation of the gene. 
Keywords: Ott-6; POU domain; Neuroectoderm; Brain development; Prosomere 
1. Introduction 
Genes involved in neurogenesis have been the subject 
of intense study in many different organisms. Many of 
these genes are members of large families and encode 
DNA binding proteins that could act as transcriptional 
regulators. These different gene families are defined by 
their evolutionary conserved DNA binding domain. One 
of these families, the POU family, consists of a growing 
number of tissue specific DNA binding proteins that share 
the conserved POU DNA binding domain (Herr et al., 
1988; Schiiler, 1991; Wegner et al., 1993). The POU do- 
main is a 150-160 amino acid region containing a 60 
amino acid POU-homeodomain (POUHD), highly ho- 
mologous with the classical homeobox, and a 75-82 
amino acid POU-specific domain (POUsp). The amino 
terminal POUsp domain is separated by a short linker 
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sequence (15-27 amino acids) from the carboxyl terminal 
POUuo domain. Based on homologies within the POU 
domain these genes have been grouped in six classes 
(classes I-VI; Wegner et al., 1993). More than 13 mam- 
malian POU family members have been identified and 
POU genes have also been cloned from the genomes of 
Drosophila (Johnson and Hirsh, 1990) C. Elegans 
(Burglin et al., 1989), Bombyx mori (Fukuta et al., 1993), 
zebrafish (Johansen et al., 1993; Hauptmann and Gerster, 
1995), chicken (Petryniak et al., 1990) and frogs 
(Agarwal and Sato, 1991). During development most 
POU genes show a tissue specific expression pattern, 
suggesting that they are involved in cell type determina- 
tion or regional specification. They will function during 
cell differentiation, regulating the tissue specific expres- 
sion of downstream genes through interaction with oc- 
tamer and octamer-like DNA elements (Rosenfeld, 1991; 
Wegner et al., 1993). 
We have been studying the Ott-6 gene, which together 
with the POU genes Brn-1, Brn-2 and Brn-4, form the 
mammalian class III POU family. We identified the 
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mouse POU factor Ott-6 as an octamer binding protein 
that is differentially expressed during neuroectodermal 
differentiation of P19 embryonal carcinoma cells (Meijer 
et al., 1990). The rapid induction of this gene in differen- 
tiating cells followed by a progressive downregulation 
and the reappearance of expression in fully differentiated 
cultures uggest that O t-6 is involved in different aspects 
of neuronal differentiation. Furthermore, Ott-6 is ex- 
pressed in non-differentiated embryonic stem cells that 
are derived from the inner cell mass (ICM) of blastocyst 
stage embryos (Meijer et al., 1990; Suzuki et al., 1990). 
The rat homolog, called SCIP or Tst-1, cloned from rat 
testis (He et al., 1989), was shown to be a CAMP (cyclic 
adenosine monophosphate) inducible gene in cultured 
neonatal Schwann cells isolated from the sciatic nerve 
(Monuki et al., 1989). 
complexes had formed the Ott-6 antibody was added to 
the binding reaction. The mobility of the Ott-1 and Ott-6 
protein complexes was found to be unaltered when pre- 
immune serum was added (Fig. la, compare lanes 1 and 
2). However, addition of Ott-6 antibody gives rise to a 
complete retardation of the Ott-6 protein complex in the 
top of the gel, whereas the Ott-1 complex was unaffected 
(Fig. la, lane 3). This experiment shows that the Ott-6 
antiserum is able to recognize mouse Ott-6 protein. Fur- 
thermore the antiserum is highly specific since it does not 
cross-react with Ott-1 protein despite the presence of a 
large excess of Ott-6 antibodies. 
Several studies have described the expression of the 
Ott-6 gene in the developing and adult central nervous 
system using RNA in situ histochemistry. During mid and 
late gestation periods of mouse embryonal development, 
Ott-6 RNA is found in the subventricular zones in the 
brain. Expression is most abundant in prospective cere- 
bral cortex, olfactory bulb, striatum, thalamus and inferior 
colliculus (Suzuki et al., 1990). In rat a similar embryonic 
expression pattern was observed (He et al., 1989). Ex- 
pression in the adult rat cerebral cortex is very prominent 
in layer 5 pyramidal neurons and is detected as these cells 
originate in the intermediate zone during embryonal de- 
velopment (Frantz et al., 1994). These RNA in situ stud- 
ies suggest that the Ott-6 gene product could be involved 
in determination of neural identity. In addition, the im- 
mediate induction of Ott-6 gene expression in P19 cell 
aggregates upon retinoic acid (RA) addition, suggests that 
Ott-6 could be involved in the differentiation of neuroec- 
todermal derivatives from a multipotent embryonic stem 
cell. However, very little is known about the expression 
of the Ott-6 gene during early mouse development. 
To further ensure the specificity of the antiserum we 
performed an affinity purification. Because the antiserum 
was raised against he full length Ott-6 protein we were 
concerned with the possibility of cross-reaction with other 
POU proteins through conserved epitopes within the POU 
domain. In addition to affinity purification we competed 
the purified Ott-6 antibodies with a cellular lysate of 
bacteria overexpressing the Ott-6 POU domain (Oct- 
6/POU) during the antibody incubation period in the im- 
munohistochemistry experiments. To determine the effi- 
ciency of this method, a similar competition was per- 
formed in a western blot assay (see Fig. lb). When whole 
cell extracts of transiently transfected COS-1 cells over- 
expressing either the Ott-6 POU domain (lanes 2 and 4) 
or the full length Ott-6 protein (lanes 1 and 3) were 
stained with the affinity purified Ott-6 antiserum, both 
Ott-6 and the Ott-6 POU domain were detected when a 
lysate of non-induced bacteria was used as a competitor 
(lanes 1 and 2). However, the Ott-6/POU competitor 
completely eliminated detection of the POU domain, 
A 
To investigate whether the expression pattern of Ott-6 
protein (rather than RNA) agrees with a role of the Ott-6 
gene in the establishment of the neuroectoderm, we per- 
formed immunohistochemical staining of early mouse 
embryos, using a polyclonal antiserum directed against 
the Ott-6 protein. 
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2. Results 
2.1. Ott-6 polyclonal antiserum free probe + 
A polyclonal antiserum was raised in rabbits against 
bacterially produced, denatured Ott-6. First, the reactivity 
of the antiserum with mouse Ott-6 protein was tested in a 
band shift assay (Fig. la). A nuclear cell extract of the 
Mes68 cell line expressing the POU proteins Ott-1 and 
Ott-6 was incubated with a radiolabeled ouble stranded 
oligonucleotide containing the octamer ATTTGCAT 
POU protein consensus binding site. After protein-DNA 
Fig. 1. Ott-6 antibodies specifically recognize Ott-6 protein. (A) A 
band shift experiment of Mes68 nuclear cell extract and a radiolabeled 
Octamer oligo. Lane 1, no serum was added; lane 2, 1~1 preimmone 
serum; lane 3, 1~1 Ott-6 antiserum. The arrow indicates the retarded 
Ott-6 protein complex. (B) A western experiment detecting either Oct- 
6 protein (lanes 1 and 3) or Oct&POU (lanes 2 and 4) under competi- 
tive conditions of a non-expressing (lanes*l-2) or Ott-6IPOU (lanes 3- 
4) expressing bacterial lysate. 
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Fig. 2. Ott-6 expression in a prestreak embryo. The figure shows an 
oblique sagittal section of a 5.5 dpc embryo. Ott-6 is expressed in the 
embryonal and extra-embryonal ectoderm. The bar represents 25ym. 
Abbreviations: ee, embryonal ectoderm; pe, proximal endoderm; xe, 
extra-embryonal ectoderm. 
leaving detection of the full length Ott-6 protein unaf- 
fected (lanes 3 and 4). This experiment demonstrates that 
addition of the POU competitor efficiently blocks the 
epitopes in the conserved POU domain while other Ott-6 
specific epitopes are still recognized by the Ott-6 antise- 
rum. Since the Ott-6 POU DNA binding domain is the 
only region with significant homology to its most closely 
related POU family members, this method eliminates any 
cross reactivity with other POU proteins. That this is also 
the case in the immunohistochemistry experiments comes 
from a number of observations not shown here. First, the 
closely related class III POU proteins Brn- 1 and Brn-4 are 
highly expressed in the developing kidney and otic vesi- 
cle, respectively (He et al., 1989; Le Moine and Young, 
1992). No signal is detected with our Ott-6 antibody in 
these structures. Second, the Brn-3 genes are highly ex- 
pressed in the sensory ganglia (Ninkina et al., 1993). No 
signal is detected with our antibody. Third, the Ott-3/4 
gene is highly expressed in the inner cell mass and tro- 
phectoderm (Scholer et al., 1990). Again no signal is de- 
tected with our antibody in these structures. These and 
numerous other observations demonstrate that the anti- 
body specifically recognizes the Ott-6 protein and none 
of the other known POU proteins. 
2.2. Ott-6 expression in presomite stage embryos 
The Ott-6 gene is expressed in inner cell mass (ICM) 
derived ES cells (Scholer et al., 1989; Meijer et al., 1990). 
To test whether the Ott-6 protein is present in the ICM of 
pre-implantation blastocyst embryos we performed im- 
munohistochemistry on whole mount blastocyst embryos. 
Using our polyclonal Ott-6 antiserum, no Ott-6 protein 
could be detected in these embryos (data not shown). This 
was not unexpected since a previous paper reported the 
failure to detect Ott-6 mRNA in these preimplantation 
embryos (Suzuki et al., 1990). However we could detect 
the Ott-6 protein in the nuclei of embryonic and extra- 
embryonic ectodermal cells of a 5.5 dpc egg cylinder 
stage embryo (Fig. 2). Thus a major period of onset of 
expression must occur sometime after or during implan- 
tation and subsequent expansion of the epiblast into a 
cylindrical structure. 
In late streak embryos, Ott-6 protein is found in the 
anterior half of the embryo. No expression is found in the 
posterior and lateral-posterior parts of the embryo (Fig. 
3a). Transverse sections of embryos of similar develop- 
mental stage revealed that Ott-6 protein is expressed in 
the cells of the ectodermal layer (data not shown). A 
sagittal section shows that the posterior boundary of ex- 
pression extends to the distal tip of the midstreak embryo 
(Fig. 3e). This position coincides with the position of the 
node. In more advanced embryos the lateral expression 
boundaries progressively restrict to a more anterior posi- 
tion (Fig. 3b,c). Furthermore, a stripe of non-expressing 
cells becomes visible at the midline of the embryo ante- 
rior of the node (Fig. 30. This becomes even more evi- 
dent in the late headfold stage embryo shown in Fig. 3c as 
the lateral boundary of expression has regressed to the 
parallel neural ridges in the headfold. Thus, during gastru- 
lation and subsequent neurulation Ott-6 protein expres- 
sion is progressively restricted to the walls of the neural 
groove after initial widespread expression in the primitive 
ectoderm. 
Besides expression in the embryonal ectoderm, Ott-6 
protein is also found in the extra-embryonal ectoderm. As 
shown in Fig. 3a-f, Ott-6 is expressed in the ectodermal 
component of the chorion membrane. This extra- 
embryonal tissue derives from both the ecto- and meso- 
derm and fuses with the allantois and ectoplacental cone 
to form the placenta. 
2.3. Ott-6 expression in 5-I 7 somite-pair stage embryos 
Formation of the head folds is initiated by invagination 
of the foregut and is characterized by exceptionally rapid 
growth of the neuroepithelial cells (see Snell and Stevens, 
1966). In 5 somite embryos, Ott-6 protein is highly ex- 
pressed in the head folds (Fig. 4a). Expression extends to 
the anterior extremity of the neuroectoderm (Fig. 4b) and 
is evenly distributed along the entire medial to lateral (M- 
L) axis of the headfolds (Fig. 4a). Proceeding in devel- 
opment, Ott-6 protein expression regresses in the hind- 
brain region in a ventral and anterior direction (Fig. 4c,d). 
The posterior boundary of expression is indicated with 
arrowheads in Fig. 4c,d and is located rostra1 of rhom- 
bomere 6. In the lateral extremities of the head folds the 
lateral and anterior boundaries of expression are regress- 
ing, leading to a more ventral position of Ott-6 express- 
ing cells in the neuroepithelium (Fig. 4~). When the ros- 
tral neuropore has closed, Ott-6 expression becomes re- 
stricted to the developing fore- and midbrain. 
188 R. Zwart et al. I Mechanisms of Development 54 (1996) 185-194 
Fig. 3. Progressive restriction of Ott-6 in the anterior ectoderm during gastruhttion. (A-C) Lateral views of whole mount embryos tained for Ott-6 
expression. Anterior is to the left. Expression restricts from a rather widespread istribution in the ectoderm to the neurepithelial cells of the neural 
groove in a head fold embryo. (A) Late streak, (8) early bud neural plate and (C) advanced head fold stage embryos. The bar represents 4OOym. (D,F) 
A lateral and anterior view, respectively, of a no bud neural plate stage embryo. (E) A sagittal section of a different embryo of similar stage. In (D) and 
(E) anterior is to the right. Expression is confined to the embryonal ectoderm and extra-embryonal chorion membrane and is absent from the midsagit- 
tal streak. The bar represents 200,~m. Abbreviations: a, amnion; ant, anterior; c, chorion; ec, ectoderm; ed, endoderm; hf, head fold; ng, neural groove; 
n, node; pos, posterior. 
2.4. Ott-6 expression in 9 to 10.5 dpc developing 
forebrain 
At 9.5 dpc Ott-6 protein expression has stabilized in 
two domains within the mid- and forebrain. A posterior 
domain encompassing the ventral aspect of the rostra1 
mesencephalon and caudal diencephalon. A second, more 
anterior expression domain is seen at the ventral midline 
of the secondary prosencephalon which extends at later 
stages into the telencephalon. (Fig. 5a). A frontal section 
of a 9.5 dpc embryo shows that in the posterior expres- 
sion domain Ott-6 is detected in the basal plate of mesen- 
cephalon and diencephalon (Fig. 5b). Furthermore a 
number of Ott-6 positive neurons can be seen at a dorsal 
position in the mid and forebrain (see Fig. 5a). Sagittal 
and transverse sections show (Fig. 5c,d) that the anterior 
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Fig. 4. Ott-6 expression in the future brain region in 5 and 17 somites 
stage embryos. (A,B) Ott-6 expression in a 5 somite embryo. (A) A 
lateral view of a whole mount stained embryo. Anterior is to the right. 
(B) A sagittal section. (CD) A lateral and dorsal view, respectively, of 
a 17 somite embryo. The arrowhead points at the posterior expression 
boundary. Bar in (A-D) represents 500~m. Abbreviations: a, amnion; 
al, allantois; F, forebrain; H, hindbrain; h, heart; hf. head fold; M, mid- 
brain; 1, first branchial arch. 
expression domain of Ott-6 is restricted rostra1 of the 
infundibular recess and caudal of the optic chiasm. Fur- 
thermore the oblique transverse section shown in Fig. 5d 
indicates that Ott-6 expression is limited by a sharp lat- 
eral boundary. The infundibular recess and Rathkes 
pouch do not express Ott-6. 
Recently, the expression patterns of a large number of 
genes have been described in the developing forebrain. 
The boundaries of mRNA expression would reflect in part 
a segmental organization of the forebrain as was proposed 
by Puelles and Rubenstein (1993) and Figdor and Stern 
(1993). In these models, the forebrain is segmentally or- 
ganized by six transverse prosomeres or four neuromeres 
which are subdivided by four longitudinal segments that 
follow the body axis. To study whether Ott-6 expression 
is confined to such segments or prosomeres, we per- 
formed whole mount RNA in situ hybridization experi- 
ments using an Ott-6 and Sonic hedgehog (Shh) probe. 
We used Shh as its expression has been described in de- 
tail (Echelard et al., 1993) , and furthermore provides a 
convenient marker for the border between prosomere 2 
and 3 (at the zona limitans intrathalamica (ZLI) = border 
between domain Dl and D2 in Figdor and Stern) and the 
ventral midline of the rostra1 diencephalon (also called the 
secondary prosencephalon). Whole mount RNA in situ 
hybridization of 9.5 dpc embryos using Shh, Ott-6 or Shh 
+ Ott-6 anti-sense RNA probes indicates that the rostra1 
boundary of the caudal Ott-6 expression domain coin- 
cides with the lateral extensions of Shh expression that 
mark the boundary between prosomere 2 and 3 (Fig. 
6a,c,e). Sense RNA probes did not detect any signal (data 
not shown). Sagittal sections of these embryos show that 
the rostra1 Ott-6 expression domain falls within the Shh 
expression domain at the ventral midline of the rostra1 
diencephalon (Fig. 6b,d). These results are schematically 
summarized in Fig. 6f. Thus Ott-6 expression in the fore- 
brain seems to be restricted to the basal segments of pro- 
somere 1, 2 and 6 according to the scheme of Puelles and 
Rubenstein. The expression of Ott-6 in the ventral 
midline of the rostra1 diencephalon is maintained at later 
stages of development but extends rostrally into the telen- 
cephalon. 
3. Discussion 
Based on in vitro cell culture systems and mRNA ex- 
pression studies in mid to late gestation embryos, it has 
been suggested that the POU factor Ott-6 plays a role in 
various aspects of neuronal differentiation. The rapid in- 
duction of Ott-6 mRNA in RA-treated P19 cell aggre- 
gates suggests that the gene product could also be in- 
volved in the establishment of the neuroectoderm in vivo. 
In this report we have described the expression pattern of 
the Ott-6 protein during early mouse development, from 
the pregastrulation stage until midgestation, using highly 
specific affinity purified antiserum in immunohistochem- 
istry experiments. 
3.1. Ott-6 and ectoderm diferentiation 
During gastrulation and subsequent neurulation, we 
found that the expression of Ott-6 protein progressively 
restricts from a rather ubiquitous expression pattern in the 
primitive ectoderm to the neuroectodermal cells in the 
neural groove of a head fold stage embryo. It appears that 
Ott-6 expression stabilizes in cells that are fated to de- 
velop into neuroectoderm whereas expression is extin- 
guished in other ectodermal derivatives. This suggests 
that Ott-6 plays a role in the progression of neuroecto- 
dermal differentiation. 
The progressive restriction of Ott-6 protein expression 
to the anterior part of the embryo is reminiscent of the 
ectodermal expression of the Otx2 gene (Ang et al., 
1994). Otxl and Otx2 are the mammalian homologs of 
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Fig. 5. Ott-6 expression in tbe developing forebrain of a 9.5 days pc embryo. (A) A ventrolateral view of a 9.5 days pc embryo. In (B) a frontal section 
is shown through the fore- and midbrain. In (C) sagittal sections show expression in the neuroepithelium of the ventral floor of the secondary prosen- 
cephalon anterior of the infundibular recess. A transverse section shows that the expression has clear lateral boundaries of expression (D). Bar in (A) 
and (B) represents 5OOpm and in (C) and (D) 150pm. Abbreviations: di, diencephalon; F, forebrain; H, hindbrain; h, heart; M, midbrain; ne, neurec- 
toderm; ov, optic vesicle; rp, Rathke’s pouch; sp, secondary prosencephalon; t, telencephalon; 1, first branchial arch; 2, second bran&al arch. 
the Drasophilu homeobox gene orthodenticle which is 
involved in the patterning of anterior head structures. 
Explant-recombination experiments performed by Ang et 
al. indicate that the progressive restriction of Otx2 ex- 
pression to the anterior part of the mouse embryo is 
brought about by a negative signal emanating from the 
posterior mesendoderm (Ang et al., 1994). This parallel in 
expression pattern suggests that Ott-6 is similarly regu- 
lated and possibly responds to the same signal that down- 
regulates Otx2. 
The restriction of Ott-6 protein expression during gas- 
trulation and neurulation is followed by a second round of 
induction of the gene in the anterior neuroectoderm. As 
the embryo develops from a late headfold stage to early 
somite stage, Ott-6 expression is detected in the primitive 
brain. This induction of high levels of Ott-6 expression 
coincides with the rapid proliferation of the anterior head- 
folds (Stevens and Snell, 1966). Again this widespread 
expression becomes restricted as the brain further devel- 
ops and adopts a segment-like pattern in the mid- and 
forebrain at the time the anterior neuropore closes. Thus, 
it appears that the early embryonic expression pattern of 
Ott-6 is the result of two separate waves of induction, 
both followed by a progressive restriction through nega- 
tive regulation of the gene. The molecules that execute 
these functions and the mechanisms by which they act are 
completely unknown. The identification of the c&acting 
DNA elements in the Ott-6 locus that regulate the devel- 
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Fig. 6.Oct-6 and Shh in situ hybridization in the developing forebrain. Lateral views of embryos tained for Ott-6 (A), 9th + Octd(C) and Shh (E) are 
shown. (B,D) Midsagittal sections of the embryos depicted in (A) and (C), respectively. Note that Ott-6 expression is contained within the Shh ex- 
pressing domain at the ventral midline of the anteriormost part of the developing forebrain. The diagram in (F) summarizes the expression patterns of 
Ott-6 (blue dots) and Shh (red stripes) at the time of rostral neuropore closure. The overlap in expression of Ott-6 and Shh in the rostrai diencephafon 
is indicated with stripes and dots on a red background. Abbreviations are; ir, infundibular recess; rp, Rathke’s pouch; oc, optic chiasm. 
opmental expression of the gene and the proteins that 
bind to these elements might give a clue towards the 
identity of the molecules involved. It is anticipated that 
negative regulatory elements will play a major role in 
establishing the expression pattern after the initial wide- 
spread activation of the gene. 
The high levels of expression of Ott-6 in the ectoderm 
of the prestreak embryo and in the primitive brain of the 
advanced headfold stage embryo coincides with a high 
proliferative activity in these structures. In postnatal 
Schwann cells high levels of Ott-6 are correlated with 
proliferation (although this correlation is not a strict one; 
see Scherer et al., 1994). Recently Faus et al. (1994) de- 
scribed the expression of Ott-6 mRNA in the highly pro- 
liferative basal layer of the skin. When cells in this layer 
start to differentiate and migrate out, Ott-6 expression is 
downregulated. In support of this, we have observed Oct- 
6 protein expression in the surface ectoderm and in the 
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hair follicles of midgestation embryos. High levels of 
Ott-6 expression in surface ectoderm were especially 
evident during the formation of the pinnae of the ear and 
the vibrissae (unpublished observations). It is therefore 
possible that one function of the Ott-6 gene is in the ex- 
pansion of undifferentiated ectodermal cells. However, 
Ott-6 expression has been seen in neurons that have 
started to differentiate and leave the ventricular zone and 
in some mature neurons, indicating that the protein might 
serve an additional function in these cells that is not re- 
lated to proliferation (Frantz et al., 1994; our unpublished 
observations). Ectopic expression and gene knock out 
studies in transgenic mice should reveal if Ott-6 is able to 
alter the developmental fate of a multi- or totipotent cell 
type in the neuronal differentiation pathway or influence 
the differentiation of other ectodermal cells that express 
Ott-6, like Schwann cells and hair follicle cells. 
3.2. Segmental expression of Ott-6 in the mid and 
forebrain 
At the time of anterior neuropore closure Ott-6 ex- 
pression has adopted a segment-like pattern in the mid- 
and forebrain (see Fig. 5). The central nervous system of 
vertebrates overlying the notochord becomes segmented 
through signaling from the segmented mesoderm (the 
somites; resulting in a secondary segmentation) or in the 
hindbrain through a program of intrinsic interactions 
(Lumsden and Keynes, 1989; Stern et al., 1991). The 
segmentation of the hindbrain and the associated neural 
crest has been extensively analyzed by tissue transplanta- 
tion and gene expression studies. It is clear that the rhom- 
bomeres represent genuine domains for cellular differen- 
tiation and cell lineage restriction (Keynes et al., 1990). 
Several developmental control genes like the hox genes 
and Krox-20 have rhombomere restricted expression pat- 
terns and gene knock out experiments in mice resulted in 
the alteration or absence of the hindbrain structures in 
which they are expressed (Carpenter et al., 1993; Krum- 
lauf, 1993; Schneider-Manoury et al., 1993; Swiatek and 
Gridley, 1993). 
Whether the mid- and forebrain in the prechordal re- 
gion also develops through a segmental subdivision is still 
a matter of debate. Morphological subdivision in the an- 
terior brain region is not as readily apparent as it is in the 
hindbrain. However, the temporal appearance of furrows 
in the forebrain has been interpreted in the light of pro- 
gressive segmentation, defining distinct adult brain 
structures. Different models have been put forward to 
describe this subdivision of the anterior brain (for discus- 
sion of these different models see Kuhlenbeck (1973) and 
Puelles and Rubenstein (1993)). The recent description of 
the restricted expression pattern of a large number of 
regulatory genes in the forebrain support he notion that 
the prechordal CNS may also develop through segmenta- 
tion of the anterior neural tube (Figdor and Stern, 1993; 
Puelles and Rubenstein, 1993; and references therein). 
Our immunohistochemistry and RNA in situ data show 
that Ott-6 expression is also confined to certain domains 
in the forebrain at the time of rostra1 neuropore closure. 
Using Shh as a secondary probe we identified the Ott-6 
expression domains as the basal segment of prosomere 1 
and 2 in the diencephalon and the ventral part of pro- 
somere 6 of the secondary prosencephalon (Fig. 6F). A 
number of regulatory genes like pax-6, BF-2, Wnt3 and 
Dlx-1 have a similar boundary (caudal or rostral) of ex- 
pression at the border between prosomere 213 which de- 
marcates the zona limitans intrathalamica (Salinas and 
Nusse, 1992; Hatini et al., 1994; Stoykova and Gruss, 
1994) This landmark also corresponds to the caudal imit 
of neuromere 1 of the diencephalon in the model of Fig- 
dor and Stern. It has been speculated that this structure 
functions as an organizer patterning the adjacent neuro- 
epithelium through planar inductive signals (Rubenstein 
et al, 1994; Bally-Cuif and Wassef, 1995). It is possible 
that these inductive signals regulate or restrict the ex- 
pression of the genes mentioned above, including Ott-6, 
to a domain caudal or rostra1 of this boundary. 
An organizing or patterning function has also been as- 
cribed to the rostral/ventral region of the forebrain in 
which Ott-6 and Shh are coexpressed. This region is able 
to induce, as is COS cell derived SHH, neurons of ventral 
telencephalic identity in prospective telencephalic neural 
plate tissue (Ericson, 1995). This suggests that a signal, 
most likely SHH, emanating from the rostra1 forebrain is 
able to pattern the ventral part of the telencephalon. Fur- 
thermore, experiments in zebrafish have suggested that 
ventral midline cells in the forebrain also function in pat- 
terning the diencephalon (Hatta, 1994). Ongoing com- 
parative expression studies for Ott-6 in chick and ze- 
brafish and gene knock out experiments in mice will 
hopefully shed some light on the possible function of the 
Ott-6 gene in these anterior brain structures. 
4. Materials and methods 
4.1. Ott-6 overexpression and purification 
For overexpression of Ott-6 protein in E. coli, a 
BamHI-BglII fragment from pN1 Ott-6, containing the 
full length Ott-6 cDNA plus the /Y-globin intron se- 
quences (Meijer et al., 1992), was cloned behind the 
IPTG inducible T7 promoter in the BamHI site of the 
pETl1A expression vector (Novagen). This construct was 
transfected into the BL21(DE3). An overnight culture 
was diluted 1 in 10 and cultured at room temperature to 
an ODm= 0.8. Overexpression was induced by adding 
IPTG to a final concentration of 0.4 mM and the culture 
was incubated for 4 h. Pilot experiments have shown 
that the Ott-6 protein can be purified by high affinity 
chromatography on a Ni-NTA matrix (Qiagen). Binding 
of Ott-6 to this matrix is probably mediated by the poly- 
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histidine stretch present in the carboxyl terminal part of 
the protein. 
For large scale purification, a 500 ml IPTG induced 
bacteria culture was pelleted, washed once with PBS, 
resuspended in 10 ml 6 M urea/PBS and sonicated. The 
cell lysate was cleared by centrifugation at 12 000 
rev./min for 5 min at 4°C. Imidazole was added to the 
supernatant to a final concentration of 0.8 mM and incu- 
bated overnight at 4°C with 300~1 Ni-NTA beads 
(Qiagen). The Ni-NTA was washed twice with 10 ml of a 
6 M urea/PBS/O.8 mM imidazole solution for 15 min and 
three times with 6 M/PBS/8 mM imidazole. Ott-6 protein 
was eluted from the matrix in 500~1 6 M urea/ 
PBS/80 mM imidazole. This purification procedure re- 
sulted in high yields of pure (>95%) and intact Ott-6 
protein as judged by Coomassie stained SDS-PAAGE. 
4.2. Antibodies 
The bacterially overexpressed Ott-6 protein was re- 
covered in 6 M urea/PBS/80 mM imidazole. To lower the 
urea concentration the eluate was dialyzed stepwise 
against PBS with decreasing concentrations of urea, to a 
final concentration of 400 mM. This led to the partial 
precipitation of Ott-6 protein. Antibodies were raised in 
White New Zealand rabbits by three consecutive injec- 
tions with 4 weeks intervals of 0.5-1.0 mg Ott-6 protein 
resuspended in incomplete Freund’s adjuvant. 
Ott-6 antibodies were affinity purified by binding to 
Ott-6 protein immobilized on nitrocellulose. After prein- 
cubation with 1% BSA/3% powdered milk/O.05% Tween- 
20/PBS for 2 h at 4”C, the nitrocellulose was incubated 
overnight with the antiserum that had been precleared 
with BL21(DE3) cell lysate at room temperature for 3 h. 
After extensive washing with PBS the Ott-6 antibodies 
were eluted from the nitrocellulose by a 3 M KSCN/ 
0.1 M NaP04/5OOpg/ml BSA solution. To remove the 
KSCN the antibody solution was passed over a 0.1 M 
NaPOh (pH 7.5) equilibrated Sephadex G-50 column. 
4.3. Band shif assay 
Nuclear protein extracts were made from the Mes68 
cell line (Meijer et al., 1990) as described by Schreiber et 
al. (1989). Band shift assays were performed as described 
(Meijer et al., 1990). 
4.4. Western blot analysis 
Cos-1 cells were transiently transfected by the CaP04 
method with 1Opg of the pNlOct-6 or pN229C520ct-6 
expression vectors encoding the complete Ott-6 protein 
or the Ott-6 POU domain respectively (Meijer et al., 
1992). Seventy-two hours after transfection whole cell 
extracts were made. Equal amounts of protein were run 
on a 10% SDS-PAAGE and blotted via semi-dry electrob- 
lotting to nitrocellulose filter. The western blot was 
blocked by overnight incubation at 4°C in a 5% powdered 
milk/PBS solution. Three 10 min washes in washing 
buffer (PBS/O.S% Tween20) were followed by 2 h incu- 
bation at 4°C with the affinity purified Ott-6 antiserum in 
PBS/O.S% BSA/O.OS% Tween20. After six 10 min washes 
it was incubated for 2 h with a 1:lOOO dilution of the anti- 
RabbitIgG alkaline phosphatase secondary antibody 
(Sigma) in PBS/O.S% BSA. After six washes in washing 
buffer the blot was washed once more in 0.2 M Tris-HCl, 
(pH 9.0), 10 mM MgCl,. The staining reaction was car- 
ried out with the BCIP/NBT substrates. 
4.5. Immunohistochemistry 
Mouse embryos were derived from natural matings of 
(CBA X BlO)Fl mice. The morning of plugging was 
determined as 0.5 days post coitum (dpc). Litters of the 
desired developmental stages were isolated, washed in 
PBS/O.S% Tween20 (PBS-T) and fixed for 2-4 h in a 
(35% acetone, 35% methanol, 5% acetic acid and 25% 
H,O) solution. After dehydration and paraffin embedding 
5 pm sections were made. The sections were mounted on 
a droplet of 10% alcohol on gelatin/chromesulfate coated 
Klinipath slides and were allowed to stretch by placing 
the slides on a hot plate at 42°C. For immunohistochemi- 
cal staining, the sections were dewaxed and rehydrated. 
All antibody incubations were done in a 10 mM NaP04 
(pH 7.5) buffer in a horizontally positioned humidified 
box. The sections were blocked for 2 h by 5% goat se- 
rum/0.05% Tween20 and washed 5 times for 10 min in 
0.5% Tween20. Incubation with the first antiserum was 
overnight. To exclude cross reactivity with other closely 
related class III POU proteins the affinity purified anti- 
Ott-6 antibodies were preincubated for 1 h with a lysate 
of Ott-6/POU overexpressing bacteria. As a control, adja- 
cent sections were stained with Ott-6 antibodies and 
competed with a non-expressing or Ott-6 expressing 
bacterial lysate. After extensive washing the secondary 
antibody incubation was performed for 2 h at room tem- 
perature. A goat-anti-Rabbit IgG secondary antibody 
(1:80 dilution) coupled to a FITC chromophore (Nordic) 
was used to visualize Ott-6 protein expression. After five 
washes in washing buffer the sections were washed with 
running tapwater followed by distilled water. The sections 
were air-dried and embedded in a 100 mg/ml DABCO/ 
70% glycerol/PBS solution (Merck). After photograph- 
ing, the sections were washed in PBS and counterstained 
with hematoxylin, dehydrated and embedded in entellan 
(Merck). 
In whole mount immunostaining experiments, anti- 
body incubations and washing steps were done in PBSTF 
(PBS/l% Triton X-100/10% fetal calf serum). Both the 
primary and secondary antibodies were incubated over- 
night. AS a secondary antibody the alkaline phosphatase 
conjugated goat-anti-rabbit antibody (Tago) was used. 
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The staining reaction was carried out with the NBT/BCIP 
substrates and stopped by washing the embryos in a 
50 mM EDTA/PBS solution. The embryos were postfixed 
in 4% paraformaldehyde/PBS and stored in the dark until 
photographed. 
4.6. Whole mount in situ hybridization 
A digoxygenin labeled Ott-6 in situ probe was gener- 
ated from a 520 bp DraI template which is located in the 
3’UTR of the Ott-6 gene. Hybridization and visualization 
with alkaline phosphatase (AP) coupled DIG antibodies 
and NBT/BCIP substrates was done as described (Charite 
et al., 1994). For double labeling experiments the Shh 
probe (Echelard et al., 1993) was fluorescein labeled and 
hybridized together with the Ott-6 probe. After staining 
of Shh with AP-coupled fluorescein antibodies and Fast 
Red substrate (Boehringer) the embryos were incubated 
for 10 min in 0.1 M glycine (pH 2.2), followed by the 
Ott-6 staining reaction (Hauptmann and Gerster, 1994). 
After postfixation in 4% paraformaldehyde/PBS the em- 
bryos were embedded in a phosphate buffered 10% gela- 
tin/30% sucrose solution for cryostat sectioning. 
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